4
Changes in Ownership
Aprea Therapeutics, Inc. Filed Acc 0001104659-21-117446
SVP, Chief Medical Officer sold 15,968 shares at $4.68 ($74,730)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Attar Eyal C. SVP, Chief Medical Officer | 2021-09-16 | Sale | −15,968 | $4.68 | $74,730 | 83,000 | D: show line 1 in the form |
| Open-market sales · 15,968 sh · avg $4.68 · $74,730 | |||||||
Loading xslF345X03/tm2127534-2_4seq1.xml…